Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FOXO1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Forkhead Box O1 transcription factor - a key regulator of cellular stress response, metabolism, and neuronal survival in neurodegenerative diseases.
| Gene Symbol | FOXO1 |
| Full Name | Forkhead Box O1 |
| Aliases | Forkhead Box O1 transcription factor |
| Chromosome | 13q14.11 |
| Protein Type | Transcription Factor |
| Target Class | Transcription Factor |
| Function | It functions as both an activator and repressor depending on cellular context and interacting partners. |
| Mechanism of Action | Small molecule modulation of protein-DNA interactions or cofactor binding |
| Druggability | Medium (0.55) |
| Clinical Stage | Phase I |
| Molecular Weight | 70 kDa |
| Amino Acids | 655 aa |
| Exons | 4 coding exons |
| Pathways | PI3K |
| UniProt ID | Q12778 |
| NCBI Gene ID | 2308 |
| Ensembl ID | ENSG00000150907 |
| OMIM | 136351 |
| GeneCards | FOXO1 |
| Human Protein Atlas | FOXO1 |
| Associated Diseases | ALS, Aging, Alzheimer, Amyotrophic Lateral Sclerosis, Cancer |
| Known Drugs/Compounds | RESVERATROL, RAPAMYCIN, Epigallocatechin gallate, Cinobufagin, resveratrol, SDHHQ |
| Interactions | CCL4, NR1H3, MAP3K5, SREBF2, NFE2L2, C1Q |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Transcriptional Autophagy-Lysosome Coupling |
| KG Connections | 1291 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
FOXO1["FOXO1"] -->|"Regulates"| LC3["LC3"]
FOXO1["FOXO1"] -->|"Associated With"| neurodegeneration["neurodegeneration"]
FOXO1["FOXO1"] -->|"Activates"| Ms["Ms"]
FOXO1["FOXO1"] -->|"Activates"| Inflammation["Inflammation"]
FOXO1["FOXO1"] -->|"Activates"| Fibrosis["Fibrosis"]
FOXO1["FOXO1"] -->|"Activates"| Cancer["Cancer"]
FOXO1["FOXO1"] -->|"Associated With"| Als["Als"]
FOXO1["FOXO1"] -->|"Associated With"| Aging["Aging"]
h_ae1b2beb["h-ae1b2beb"] -->|"Targets Gene"| FOXO1["FOXO1"]
BAX["BAX"] -->|"Associated With"| FOXO1["FOXO1"]
EHMT2["EHMT2"] -->|"Associated With"| FOXO1["FOXO1"]
JUN["JUN"] -->|"Inhibits"| FOXO1["FOXO1"]
SOD2["SOD2"] -->|"Activates"| FOXO1["FOXO1"]
style FOXO1 fill:#8d4900,color:#e0e0e0
style LC3 fill:#8d4900,color:#e0e0e0
style neurodegeneration fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Inflammation fill:#b71c1c,color:#e0e0e0
style Fibrosis fill:#b71c1c,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Als fill:#b71c1c,color:#e0e0e0
style Aging fill:#b71c1c,color:#e0e0e0
style h_ae1b2beb fill:#607D8B,color:#e0e0e0
style BAX fill:#8d4900,color:#e0e0e0
style EHMT2 fill:#8d4900,color:#e0e0e0
style JUN fill:#8d4900,color:#e0e0e0
style SOD2 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Liver Fibrosis | protects_against | disease | 0.95 |
| Hepatocytes | expressed_in | cell_type | 0.95 |
| hepatocyte apoptosis | promotes | process | 0.95 |
| Myogenesis | regulates | process | 0.95 |
| Amyotrophic Lateral Sclerosis | mediates | disease | 0.95 |
| ALS | mediates | disease | 0.95 |
| TGFB1 | upregulates | gene | 0.92 |
| Myogenesis | inhibits | process | 0.92 |
| Tgfb1 Expression | regulates | process | 0.91 |
| CCL4-induced Liver Injury | protects_against | disease | 0.90 |
| Liver Fibrosis | regulates | disease | 0.90 |
| Hepatic Inflammation | regulates | process | 0.90 |
| Hepatic Inflammation | promotes | process | 0.90 |
| Hepatic Stellate Cell Activation | promotes | process | 0.90 |
| TGFB1 | mediates | protein | 0.90 |
| GH1 | upregulates | gene | 0.90 |
| SOD2 | upregulates | gene | 0.90 |
| CAT | upregulates | gene | 0.90 |
| Glucose Metabolism | regulates | process | 0.90 |
| Hepatocyte | expressed_in | cell_type | 0.90 |
| Reactive Oxygen Species | regulates | process | 0.90 |
| AKT | activates | gene | 0.90 |
| Ccl4-Induced Liver Injury | contributes_to | phenotype | 0.88 |
| Energy Homeostasis | regulates | process | 0.88 |
| Motor Nerve Terminal Dysfunction | inhibits | phenotype | 0.88 |
| Hsc Activation | modulates | process | 0.87 |
| Cell Proliferation | regulates | process | 0.85 |
| Pi3K-Akt Signaling | mediates | pathway | 0.85 |
| Glucose Oxidation | regulates | process | 0.85 |
| Motor Abnormalities | inhibits | phenotype | 0.85 |
| glycogen synthesis | regulates | process | 0.85 |
| GH1 | binds | gene | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| Diabetes | regulates | disease | 0.85 |
| Cancer | regulates | disease | 0.85 |
| Tumor | activates | disease | 0.85 |
| TGF-β1 | regulates | protein | 0.85 |
| Inflammation | inhibits | process | 0.85 |
| apoptosis | promotes | process | 0.85 |
| Non-Alcoholic Fatty Liver Disease | regulates | disease | 0.82 |
| OPTN | regulates | gene | 0.81 |
| Cell Migration | regulates | process | 0.80 |
| Cell Invasion | regulates | process | 0.80 |
| liver fibrosis | prevents | disease | 0.80 |
| cell proliferation | suppresses | process | 0.80 |
| antioxidant production | promotes | process | 0.80 |
| Antioxidant Production | promotes | process | 0.80 |
| ATG | regulates | gene | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TAZ | activates | gene | 0.95 |
| PI3K/AKT1 | inhibits | pathway | 0.90 |
| SDHHQ | modulates | drug | 0.90 |
| cAMP/PKA signaling pathway | upregulates | pathway | 0.90 |
| h-ae1b2beb | targets_gene | hypothesis | 0.90 |
| Carbon Tetrachloride | upregulates | compound | 0.88 |
| PI3K-Akt Signaling | regulates | pathway | 0.85 |
| G9A | regulates | protein | 0.85 |
| AKT1 | regulates | protein | 0.85 |
| Epigallocatechin gallate | targets | compound | 0.85 |
| Cinobufagin | activates | compound | 0.85 |
| AKT1 | inhibits | protein | 0.85 |
| EHMT2 | inhibits | gene | 0.85 |
| YAP1 | binds | protein | 0.82 |
| h-ae1b2beb | targets | hypothesis | 0.80 |
| G9a | regulates | enzyme | 0.80 |
| DAPK1 | regulates | gene | 0.80 |
| AKT1 | phosphorylates | gene | 0.80 |
| Cinobufagin | upregulates | compound | 0.80 |
| USP1 | interacts_with | gene | 0.80 |
| SOD2 | activates | gene | 0.70 |
| PI3K | regulates | gene | 0.70 |
| PTEN | phosphorylates | gene | 0.70 |
| PTEN | activates | gene | 0.70 |
| APOPTOSIS | regulates | gene | 0.70 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| METFORMIN | activates | drug | 0.70 |
| STROKE | activates | disease | 0.70 |
| MELATONIN | activates | drug | 0.70 |
| HEPATOCYTES | treats | cell_type | 0.65 |
| MELATONIN | interacts_with | drug | 0.65 |
| MAPK | interacts_with | gene | 0.65 |
| BAX | associated_with | gene | 0.60 |
| EHMT2 | associated_with | gene | 0.60 |
| JUN | inhibits | gene | 0.60 |
| PPARGC1A | therapeutic_target | gene | 0.60 |
| SIRT3 | therapeutic_target | gene | 0.60 |
| PRKAA1 | therapeutic_target | gene | 0.60 |
| CREBBP | therapeutic_target | gene | 0.60 |
| PPARA | interacts_with | gene | 0.60 |
| ULK1 | interacts_with | gene | 0.60 |
| STX17 | interacts_with | gene | 0.60 |
| SQSTM1 | interacts_with | gene | 0.60 |
| NOS3 | interacts_with | gene | 0.60 |
| STING1 | interacts_with | gene | 0.60 |
| GLP1R | interacts_with | gene | 0.60 |
| SREBF1 | interacts_with | gene | 0.60 |
| SIRT1 | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Transcriptional Autophagy-Lysosome Coupling | 0.665 | neurodegeneration | Autophagy-lysosome pathway convergence a |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.665
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] | Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang | Cell Mol Gastroenterol Hepatol | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] | Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji | J Ethnopharmacol | 2022 | 1 |
| Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] | Wang Y, An H, Liu T, Qin C, Sesaki H, Gu | Cell Rep | 2019 | 1 |
| AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] | Song X, Zhu S, Chen P, Hou W, Wen Q, Liu | Curr Biol | 2018 | 1 |
| Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] | Cid-Díaz T, Santos-Zas I, González-Sánch | J Cachexia Sarcopenia Muscle | 2017 | 1 |
| PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736] | Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K | Cell reports | 2026 | 0 |
| Mammalian lipophagy: process and function. [PMID:41681129] | Zhao R, Dai E, Kang R, Liu J, Klionsky D | Autophagy | 2026 | 0 |
| TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828] | ["Xin Y", "Sun Y", "Pan E", "Li M", "Che | Free radical biology & medicin | 2026 | 0 |
| Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545] | Cao X, Shang Y, Qu M, Kang Q, Xu Y et al | Phytomedicine | 2026 | 0 |
| A PI3Kδ-Foxo1-FasL signaling amplification loop rewires CD4+ T cell signaling an [PMID:41718717] | Golec DP, Gazzinelli-Guimaraes PH, Chaus | J Exp Med | 2026 | 0 |
| Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754] | Contreras EJ, Nagarajan A, Bromberg BH, | Food Res Int | 2026 | 0 |
| FOXO1 transcription factor modulates airway epithelial responses to viral infect [PMID:41931532] | Daniel NM, Mann-Nüttel R, Shrestha Palik | PLoS One | 2026 | 0 |
| Clinical and immunological significance of FOXO1 as a biomarker of improved resp [PMID:41935603] | Du L, Wang J, Wang Y, Wang H, Xu X et al | Eur J Pharmacol | 2026 | 0 |
| Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cell [PMID:41945556] | Yan Z, Chi W, Yan Z, Wang H | PLoS One | 2026 | 0 |
| Ponatinib inhibits LCK and PI3K signaling and promotes CD8(+) T stem cell memory [PMID:41946709] | Okuhiro Y, Ito S, Watanabe K, Yan Y, Kum | Nat Commun | 2026 | 0 |
| Loss of FoxO in skeletal muscle leads to disrupted muscle metabolism and exacerb [PMID:41950099] | Oyabu M, Sakaue M, Kubo A, Yoshioka K, K | Proc Natl Acad Sci U S A | 2026 | 0 |
| The deubiquitinase activity of CYLD is required for B cell differentiation. [PMID:41951576] | Pseftogas A, Bordini J, Gavriilidis G, F | Cell Death Dis | 2026 | 0 |
| Effects of Vitamin A Restriction on Carcass Characteristics, Antioxidant Capacit [PMID:41856090] | Zhang X, Zhang C, Song J, Bai J, Hao B, | Animal bioscience | 2026 | 0 |
| Transcriptomic identification of CREB1 and FOXO1 activation in neuregulin-1-medi [PMID:41907189] | Bennett KR, Surles-Zeigler MC, Augello C | Frontiers in molecular neurosc | 2026 | 0 |